|
Giving voice to patients: Understanding treatment preferences of patients with multiple myeloma (MM). |
|
|
Employment - Janssen Scientific Affairs; Merck |
Stock and Other Ownership Interests - Merck |
|
|
Employment - Janssen Scientific Affairs |
Stock and Other Ownership Interests - Janssen Scientific Affairs |
|
|
Employment - Bristol-Myers Squibb; Janssen Scientific Affairs |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
|
|
Employment - Sarokin Consulting |
Leadership - Sarokin Consulting |
Consulting or Advisory Role - Sarokin Consulting |
|
M. Janelle Cambron-Mellott |
No Relationships to Disclose |
|
|
Employment - Kantar Health |
Consulting or Advisory Role - Kantar Health |
|
|
Employment - Kantar Health |
Consulting or Advisory Role - Kantar Health |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Merck; Novartis; Takeda |
Research Funding - AstraZeneca (Inst) |